News
Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...
"Our data highlight the durability of SARS-CoV-2 immune responses, but they also suggest that updated vaccines to target new variants could further enhance immunity, especially in those previously ...
New research links multisystem inflammatory syndrome in children with COVID-19 to Epstein-Barr virus reactivation, revealing ...
The following is a summary of “A gold nanoparticle/peptide vaccine designed to induce SARS-CoV-2-specific CD8 T cells: a double-blind, randomized, phase 1 study in Switzerland,” published in the April ...
Peer-Reviewed Data Reinforces GeoVax's Multi-Antigen Strategy With GEO-CM02 and Supports Advancement of GEO-CM04S1 Clinical ...
8d
News-Medical.Net on MSNScientists stop long-COVID symptoms in mice using a new antiviral compoundAustralian scientists developed a novel antiviral that targets the SARS-CoV-2 PLpro enzyme, showing strong preclinical ...
The following is a summary of “Recall vaccination increases detectable B-cell reactivity in persons with multiple sclerosis treated with ocrelizumab,” published in the April 2025 issue of Journal of ...
SINGAPORE, April 17, 2025 /PRNewswire/ -- T Cell Diagnostics Pte. Ltd. ("TCD") has licensed an intellectual property (IP) and ...
Three doses of COVID-19 mRNA vaccination induce long-lasting antibody and memory B-cell responses, according to a study of 113 healthcare workers in Catalonia who were followed during three years. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results